EMA ’s CHMP grants positive opinion for Allergan’s IBS-D treatment in Europe

The European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Allergan’s Truberzi (eluxadoline) in the European Union (EU) to treat adults with irritable bowel syndrome with diarrhoea (…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news